Nutri Pharmaceuticals Research Inc (NRPR)

[veritas-twj]

NRPR 10/26/07 : Positive Fundamental Expectation for NRPR (Nutri Pharmaceuticals Research, Inc.)

October 26, 2007 - 8:31 AM EDT

With just 90 days to go until the close of our fiscal year it is a good time to take a look at where we are as of now and where we expect to be by year-end and into 2008.

Revenue:

2007 was a building year with results up modestly compared to the prior year. Prospects for next year and subsequent periods should be much improved.

Orders and shipments are both up significantly through the first 25 days of this quarter and we are beginning to see some positive, early returns with our strategic alliances in both the nutraceutical and functional food markets. We anticipate sales and net income to exceed our 2006 performance but at a slightly slower pace than originally forecast.

Strategic Alliances:

At the close of the 3rd quarter, we established two significant strategic alliances to broaden our presence in our core nutraceutical business, as well as accelerate our entry into the expanding functional foods market.

Partnering with a strong, well-established leader in specialty ingredients to nutraceutical, OTC, food marketing and cosmetic manufacturers, NPRI has strengthened our presence among the country’s top 100 nutraceutical product marketing and contract manufacturing firms.

Similarly, an alliance with one of the leading Tier 1 suppliers to the food and confectionary industries will enable us to gain immediate access to food giants.

Earlier in September, we announced our collaboration with Baylor University’s Institute of Metabolic Disease University on the development of a unique medium-odd chain fatty acid formulation for the reduction of muscle weakness and degeneration. Researchers at Baylor are excited about our O2P technology and how it has been instrumental in accelerating clinical trials and in expanding the potential health benefits of their proposed therapy.

Product News:

At the close of the 2nd quarter, we have begun to realize the commercialization of our long-anticipated high concentrate omega-3 powder. This powder contains a significantly higher dosage of DHA compared to other omega-3s which many food and nutraceutical companies are requiring as they expand their omega-3 product portfolios.

We have also begun to market unique combinations of omega-3 oils and other free-fatty acids with functional carrier matrices to commercial bakers and snack food manufacturers combining omega-3 oil with fiber or omega-3 oil with protein, merging the health benefits of omega-3 with known benefits of fiber or protein.

Specialty allergen-free proteins with cocoa powder are being promoted to the meal replacement and powdered drink manufacturers.

Facility Update:

In October 2006, we relocated our headquarters and manufacturing plant, moving into a 32,000 sq. ft., state-of-the-art food-grade facility. Early in 2007, we completed consolidation of administration and manufacturing services and received Halal (IFANCA), Kosher (Circle K) and USDA certification. The company is continuing to pursue GMP certification which we anticipate yet this year or early 2008.

Summary:

Where 2007 was initially perceived as a year of confirmation and consolidation, it would appear that it could also indicate the start of a significant acceptance of and reliance upon the O2P technology particularly in functional food applications, and the start of a breakout in sales, market growth and product innovation.

We have a proven, proprietary technology, produced in a world-class facility that will meet or exceed current industry requirements for quality, reliability and safety, with a sales infrastructure in the key economies of Europe, Asia and North America, and an expanding client base that includes many familiar food marketing and consumer brand names known worldwide.

Nutri Pharmaceuticals Research (Pink Sheets: NRPR) has proprietary research and technology for converting oils to powders without altering the molecular structure of the oil in the powder state with existing sales in both domestic and international markets.

Princeton Research, Inc
Mike King, 702-650-3000
[e-mail]

Source: Business Wire (October 26, 2007 - 8:31 AM EDT)

News by QuoteMedia
www.quotemedia.com